Pharma News - Chemdiv

$Lenvatinib Significantly Improved Overall Survival in Older Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer$

Lenvatinib Significantly Improved Overall Survival in Older Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer

WOODCLIFF LAKE, NJ, USA I August 28, 2017 I Eisai Inc.

U.S. FDA and European Medicines Agency Accept Regulatory Submissions for BOSULIF® (bosutinib) for the Treatment of Patients with Newly Diagnosed Ph+ Chronic Myeloid Leukemia

LONDON, UK & NEW YORK, NY, USA I August 29, 2017 I Pfizer Inc.

Bayer announces enrollment of first U.S. patient in Phase III trials of vilaprisan in uterine fibroids

WHIPPANY, NJ, USA I August 29, 2017 I Bayer announced that the first U.

A first: Drug lowers heart attack risks by curbing inflammation

For the first time, a drug has helped prevent heart attacks by curbing inflammation, a new and very different approach than lowering cholesterol, the focus for many years.

FDA Approves Second Humira Biosimilar, Cyltezo

The US Food and Drug Administration (FDA) has approved adalimumab-adbm (Cyltezo, Boehringer Ingelheim) for multiple indications.

Mycosis Fungoides and Sezary Syndrome Treatment Gets Breakthrough Therapy Designation

Breakthrough Therapy Designation status has been granted to Kyowa Hakko Kirin Co, Ltd.

Gilead to buy Kite for promising cancer therapies in $12 billion deal

(Reuters) - Gilead Sciences Inc agreed to buy Kite Pharma Inc in a $11.

Statins may help combat typhoid, malaria

The findings give insight into the mechanisms that govern human susceptibility to infectious disease and point to possible avenues to protect against pathogens like Salmonella or Ebola that hijack cho...

Artificial Intelligence system may help detect melanoma skin cancer

Toronto.

Paratek Pharmaceuticals soars after revealing it is to appear at five investor conferences

Two biotechs - Paratek and Intra-Cellular - were the stocks to have on Wednesday morning.

High levels of lithium in tap water linked to lowered rates of dementia

(Medical Xpress)—A team of researchers from several institutions in Denmark has found what appears to be a link between the amount of lithium naturally present in tap water and dementia in t...

Octapharma gets FDA approval for new product strengths of NUWIQ

HOBOKEN, N.